Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
Clinical Trial to Evaluate the Efficacy and Safety of DP-R212
The purpose of this study is to determine superiority of DP-R212 comparing to each
 monotherapy in patient with hypertension and primary hypercholesterolemia.
Inclusion Criteria:

 -  Both man and woman who is over 19 years old

 -  Hypertension patient with hypercholesterolemia

 Exclusion Criteria:

 -  sSBP difference is ≥20mmHg or sDBP difference is ≥10mmHg

 -  A history of cardiovascular disease

 -  rhabdomyolysis, myopathy

 -  Hypertension or hypercholesterolemia due to secondary causes

 -  Uncontrolled diabetes

 -  Evidence of hepatic or renal disease